e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Respiratory infections and inflammations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vitro
infection with nontypeable
Haemophilus influenzae
in a model of human lung tissues and cells
F. Xu, D. Droemann, J. Rupp, T. Goldmann, M. Maass, S. Krueger, P. Zabel, K. Dalhoff (Luebeck, Germany; Hangzhou, China)
Source:
Annual Congress 2005 - Respiratory infections and inflammations
Session:
Respiratory infections and inflammations
Session type:
Thematic Poster Session
Number:
2586
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Xu, D. Droemann, J. Rupp, T. Goldmann, M. Maass, S. Krueger, P. Zabel, K. Dalhoff (Luebeck, Germany; Hangzhou, China).
In vitro
infection with nontypeable
Haemophilus influenzae
in a model of human lung tissues and cells. Eur Respir J 2005; 26: Suppl. 49, 2586
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Establishment of Nontypeable Haemophilus influenzae airway infection murine model
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Infection pattern and inflammatory response in acute and persistent nontypeable
haemophilus influenzae
(NTHi) infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006
Monocyte/macrophage killing of nontypeable haemophilus influenzae
Source: Eur Respir J 2006; 28: Suppl. 50, 577s
Year: 2006
Haemophilus influenzae
persists in biofilm communities in a smoke-exposed ferret model of COPD
Source: ERJ Open Res, 6 (3) 00200-2020; 10.1183/23120541.00200-2020
Year: 2020
Study on human tracheal bronchial epithelial cells secreting cytokines in vitro by nontypeable haemophilus influenzae
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
LSC Abstract – Extracellular vesicle release by macrophages during infection with non-typeable Haemophilus influenzae
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Chronic infection by nontypeable
Haemophilus influenzae
fuels airway inflammation
Source: ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020
Year: 2021
Non-typeable Haemophilus influenzae biofilm formation on air-liquid interface cultured primary human airway epithelia
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Primary ciliary dyskinesia exhibits dysregulated epithelial responses to non-typeable Haemophilus influenzae
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017
The response of macrophages to Moraxella catarrhalis infection
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
The persistence of Nontypeable Haemophilus Influenzae fuels type 17 immunity in the lung
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Macrophage inflammatory responses to Non-typeable Haemophilus influenzae (NTHi) are strain-dependent
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Moraxella catarrhalis infection of healthy and COPD ciliated epithelial cultures
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
PP311 – Nontypeable Haemophilus influenzae supresses SP-B and SP-C expression in alveolar epithelial type II cells
Source: ERS Lung Science Conference 2021
Year: 2021
Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Cellular and cytokine profile following
in vivo
challenge with nontypeable
haemophilus influenzae
in cigarette smoke exposed mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Effect of corticosteroids on innate and adaptive T cell responses to non-typeable Haemophilus influenzae
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
NETosis induced by Haemophilus Influenzae disrupts the lung epithelial barrier
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept